The cervical cancer vaccine is currently divided into three types, bivalent vaccine, quadrivalent vaccine and nine-valent vaccine, and the specific vaccination arrangements are as follows: 1. bivalent vaccine is applicable to women aged 9-25 years old, and a total of three doses are required to complete the whole process, one in the zero month, one in the first month and one in the sixth month; 2. quadrivalent vaccine is applicable to women aged 20-45 years old, and a total of three doses are required to complete the whole process, one in the zero month, one in the second month and one in the sixth month; 3. 3. The nine-valent HPV vaccine is suitable for women aged 16-26 years old and requires three doses, one each in the first, second and sixth months. HPV vaccination is not a complete substitute for cervical cancer screening, so regular TCT and HPV checkups are also required after cervical cancer vaccination.